STAA STAAR Surgical Company - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$22.47
· of 52w range
· above low
· to high
$15.6552w low
$35.8752w high
Market Cap
$1.11B
P/E (TTM)
280.9
EPS (TTM)
$0.08
Revenue (TTM)
$340M
your badges
52W Range
$16–$36
Analyst Rating
HOLD
Price Target
$28
P/E
280.9
ROE
-23.6%
Net Profit Margin
1.1%
Your badge strip is empty — pin a metric anywhere on this page.
STAA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$22.47
Market Cap
$1.11B
P/E (TTM)
280.9
EPS (TTM)
$0.08
Revenue (TTM)
$340M
ROE
-23.6%
52W Range
$16–$36
STAA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 18, 1992 | 1-for-2 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$239M2017-12-29 → 2026-01-02
EPS$-1.622017-12-29 → 2026-01-02
Free Cash Flow$-40M2017-12-29 → 2026-01-02
Net margin1.1%2018-12-28 → 2026-01-02
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | STAA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 280.95Y avg ≈44.5 | ≈44.5 | 28.6 | Overvalued | |
| P/S | 4.65Y avg ≈8.4 | ≈8.4 | 2.0 | Overvalued | |
| P/B | 3.25Y avg ≈6.8 | ≈6.8 | 2.5 | Pricier | |
| Price / FCF | -27.75Y avg ≈-66.4 | ≈-66.4 | · | · | |
| Price / Cash Flow | -32.45Y avg ≈62.2 | ≈62.2 | · | · | |
| Price / Tangible Book | 3.25Y avg ≈6.8 | ≈6.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | STAA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 76.6%5Y avg ≈77.4% | ≈77.4% | 56.4% | Top tier | |
| Operating Margin (TTM) | 4.0%5Y avg ≈-0.75% | ≈-0.75% | 8.1% | Top tier | |
| EBITDA Margin | -38.3%5Y avg ≈-0.75% | ≈-0.75% | 10.8% | In line | |
| Pretax Margin (TTM) | 5.1%5Y avg ≈0.56% | ≈0.56% | 6.1% | Top tier | |
| Net Profit Margin (TTM) | 1.1%5Y avg ≈-1.8% | ≈-1.8% | 3.8% | Top tier | |
| ROA | -16.7%5Y avg ≈0.44% | ≈0.44% | -3.8% | Weak | |
| ROE | -23.6%5Y avg ≈-0.29% | ≈-0.29% | -12.5% | Weak | |
| ROIC | -26.1%5Y avg ≈-1.4% | ≈-1.4% | -0.66% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | STAA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 4.55Y avg ≈5.4 | ≈5.4 | 2.5 | Strong liquidity | |
| Quick Ratio | 3.55Y avg ≈4.6 | ≈4.6 | 1.3 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | STAA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -23.7%5Y avg ≈10.6% | ≈10.6% | · | · | |
| Revenue CAGR 3Y | 0.00%5Y avg ≈12.1% | ≈12.1% | · | · | |
| Revenue CAGR 5Y | 7.9% | · | · | · | |
| EPS YoY | -46.2%5Y avg ≈121.1% | ≈121.1% | · | · | |
| Net Income YoY | -46.2%5Y avg ≈121.1% | ≈121.1% | · | · | |
| EPS CAGR 3Y | 53.0% | · | · | · | |
| Net Income CAGR 3Y | 53.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | STAA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.55Y avg ≈0.7 | ≈0.7 | 0.7 | Weak | |
| Receivables Turnover | 3.75Y avg ≈4.5 | ≈4.5 | 6.1 | Weak | |
| Revenue / Employee | ≈$260.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-35.1%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $0.16 | $0.16 | -1.4% |
| March 31, 2026 | May 13, 2026 | $0.23 | $-0.07 | 453.8% |
| Dec. 31, 2025 | $-0.37 | $0.06 | -734.6% | |
| Sept. 30, 2025 | $0.18 | $0.16 | 9.3% | |
| June 30, 2025 | $-0.34 | $-0.67 | 49.6% | |
| March 31, 2025 | $-0.53 | $-0.61 | 12.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239M | $314M | $322M | $239M | $230M | $163M | $150M | $124M | $91M | $82M | · | · | |
| Cost of Revenue | $57M | $74M | $70M | $61M | $52M | $45M | $38M | $32M | $26M | $24M | $24M | $26M | |
| Gross Profit | $182M | $240M | $253M | $223M | $179M | $118M | $112M | $92M | $64M | $58M | $53M | $49M | |
| R&D Expense | $40M | $45M | $40M | $36M | $34M | $32M | $25M | $22M | $20M | $21M | $15M | $12M | |
| SG&A Expense | $274M | $252M | $225M | $180M | $145M | $112M | $100M | $85M | $68M | $71M | $20M | $18M | |
| Operating Income | $-92M | $-13M | $28M | $44M | $33M | $7M | $12M | $7M | $-4M | $-13M | $-5M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $112.0K | $112.0K | $78.0K | $154.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | $3.0K | $50.0K | $51.0K | |
| Other Non-op | $2M | $815.0K | $448.0K | $205.0K | $-48.0K | $-44.0K | $152.0K | $82.0K | $47.0K | $-148.0K | $19.0K | $26.0K | |
| Pretax Income | $-82M | $-9M | $34M | $46M | $31M | $8M | $13M | $7M | $-2M | $-12M | $-6M | $-9M | |
| Income Tax | $-2M | $11M | $12M | $6M | $4M | $2M | $-1M | $2M | $-157.0K | $-315.0K | $928.0K | $-253.0K | |
| Net Income | $-80M | $-20M | $21M | $40M | $28M | $6M | $14M | $5M | $-2M | $-12M | $-7M | $-8M | |
| EPS (Basic) | $-1.62 | $-0.41 | $0.44 | $0.83 | $0.58 | $0.13 | $0.32 | $0.12 | $-0.05 | $-0.30 | $-0.17 | $-0.22 | |
| EPS (Diluted) | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 | $-0.17 | $-0.22 | |
| Shares (Basic) | 49,568,000 | 49,125,000 | 48,523,000 | 47,987,000 | 47,210,000 | 45,605,000 | 44,493,000 | 42,587,000 | 41,004,000 | 40,329,000 | 39,260,000 | 38,091,000 | |
| Shares (Diluted) | 49,568,000 | 49,125,000 | 49,427,000 | 49,380,000 | 49,456,000 | 47,953,000 | 46,895,000 | 45,257,000 | 41,004,000 | 40,329,000 | 39,260,000 | 38,091,000 | |
| EBITDA | $-92M | $-13M | $28M | $44M | $33M | $7M | $12M | $7M | $-4M | $-13M | $-5M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $153M | $144M | $183M | $86M | $200M | $152M | $120M | $104M | $19M | $14M | $13M | $13M | |
| Short-term Investments | $34M | $86M | $38M | $125M | · | · | · | · | · | · | · | · | |
| Receivables | $50M | $78M | $95M | $62M | $44M | $35M | $31M | $26M | $18M | $16M | $16M | $11M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | $16M | $16M | |
| Prepaid Expense | $8M | $8M | $6M | $4M | $4M | $3M | $3M | $2M | $1M | $1M | $971.0K | $2M | |
| Other Current Assets | $367.0K | $998.0K | $762.0K | $811.0K | $636.0K | $1M | $453.0K | $305.0K | $197.0K | $484.0K | $470.0K | $383.0K | |
| Current Assets | $312M | $368M | $365M | $312M | $271M | $216M | $175M | $152M | $54M | $50M | $49M | $45M | |
| PP&E (Net) | $73M | $85M | $67M | $51M | $36M | $24M | $17M | $11M | $10M | $12M | $10M | $10M | |
| PP&E (Gross) | $113M | $118M | $95M | $89M | $70M | $56M | $46M | $39M | $35M | $37M | $33M | $31M | |
| Accum. Depreciation | $40M | $34M | $28M | $38M | $34M | $32M | $29M | $27M | $26M | $25M | $23M | $21M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | · | · | · | $173.0K | $218.0K | $270.0K | $296.0K | $243.0K | $271.0K | $473.0K | $666.0K | $870.0K | |
| Other Non-current Assets | $1M | $1M | $3M | $957.0K | $822.0K | $608.0K | $751.0K | $1M | $967.0K | $772.0K | $617.0K | $597.0K | |
| Total Assets | $452M | $510M | $489M | $419M | $346M | $257M | $208M | $167M | $68M | $65M | $63M | $59M | |
| Accounts Payable | $12M | $17M | $14M | $12M | $9M | $7M | $8M | $7M | $6M | $8M | $7M | $7M | |
| Current Liabilities | $69M | $70M | $65M | $52M | $49M | $41M | $34M | $28M | $19M | $21M | $18M | $16M | |
| Capital Leases | $32M | $35M | $31M | $27M | $28M | $7M | $4M | $459.0K | $531.0K | $1M | $204.0K | $468.0K | |
| Deferred Tax | · | $297.0K | $1M | $1M | $811.0K | $222.0K | $658.0K | $2M | $2M | $4M | $1M | $2M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $75.0K | |
| Total Liabilities | $107M | $112M | $103M | $83M | $87M | $60M | $48M | $35M | $25M | $28M | $24M | $22M | |
| Common Stock | $498.0K | $493.0K | $488.0K | $482.0K | $477.0K | $464.0K | $448.0K | $442.0K | $414.0K | $407.0K | $399.0K | $384.0K | |
| Retained Earnings | $-148M | $-68M | $-47M | $-69M | $-108M | $-136M | $-142M | $-156M | $-161M | $-159M | $-147M | $-140M | |
| Treasury Stock | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $-7M | $-7M | $-4M | $156.0K | $-4M | $-6M | $-3M | $-1M | $-1M | $-1M | $-2M | $-1M | |
| Stockholders' Equity | $344M | $397M | $386M | $336M | $262M | $197M | $160M | $132M | $43M | $38M | $39M | $37M | |
| Liabilities + Equity | $452M | $510M | $489M | $419M | $346M | $257M | $208M | $167M | $68M | $65M | $63M | $59M | |
| Shares Outstanding | 49,403,000 | 49,294,000 | 48,839,000 | 48,212,000 | 47,716,000 | 46,488,000 | 44,822,000 | 44,195,000 | 41,383,000 | 40,732 | 39,887 | 38,429 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $31M | $27M | $24M | $20M | $15M | $12M | $11M | $7M | $3M | $9M | $3M | $5M | |
| Deferred Tax | $-3M | $4M | $3M | $-2M | $-2M | $-849.0K | $-3M | $441.0K | $-547.0K | $-1M | $473.0K | $-841.0K | |
| Amort. of Intangibles | · | · | $13.0K | $28.0K | $34.0K | $35.0K | $34.0K | $34.0K | $221.0K | $228.0K | $205.0K | $382.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $321.0K | |
| Operating Cash Flow | $-34M | $16M | $15M | $36M | $44M | $21M | $26M | $13M | $3M | $1M | $-2M | $-8M | |
| CapEx | $6M | $23M | $18M | $18M | $14M | $8M | $10M | $2M | $1M | $3M | $2M | $4M | |
| Investing Cash Flow | $46M | $-59M | $74M | $-156M | $-14M | $-8M | $-10M | $-2M | $-1M | $-3M | $-2M | · | |
| Stock Issued | · | · | · | · | · | · | · | $72M | · | · | · | · | |
| Stock Repurchased | $6M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $6M | $7M | $8M | $18M | $20M | $149.0K | $75M | $2M | $3M | $5M | · | |
| Net Change in Cash | $9M | $-39M | $97M | $-113M | $47M | $32M | $16M | $85M | $5M | $597.0K | $389.0K | $-10M | |
| Taxes Paid | $8M | $11M | $3M | · | · | · | · | · | · | $699.0K | $589.0K | $1M | |
| Free Cash Flow | $-40M | $-8M | $-4M | $18M | $30M | $13M | $16M | $11M | $2M | $-2M | $-4M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $2M | $-2M | $-4M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.2% | 76.3% | 78.4% | 78.5% | 77.5% | 72.4% | 74.5% | 73.8% | · | · | · | · | |
| Operating Margin | -38.3% | -4.0% | 8.7% | 15.4% | 14.5% | 4.1% | 7.9% | 5.3% | · | · | · | · | |
| Net Margin | -33.6% | -6.4% | 6.6% | 13.6% | 10.6% | 3.6% | 9.3% | 4.0% | · | · | · | · | |
| Pretax Margin | -34.4% | -2.9% | 10.4% | 16.0% | 13.6% | 5.1% | 8.7% | 5.4% | · | · | · | · | |
| EBITDA Margin | -38.3% | -4.0% | 8.7% | 15.4% | 14.5% | 4.1% | 7.9% | 5.3% | · | · | · | · | |
| ROA | -16.7% | -4.0% | 4.7% | 10.2% | 8.1% | 2.5% | 7.5% | 4.2% | -3.2% | -18.9% | -10.7% | · | |
| ROE | -23.6% | -4.9% | 5.6% | 11.8% | 9.7% | 3.1% | 9.1% | 3.8% | -5.3% | -31.6% | -17.2% | · | |
| ROIC | -26.1% | -7.1% | 4.6% | 11.2% | 10.1% | 2.5% | 8.0% | 3.7% | -7.9% | -32.5% | -16.0% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 5.2 | 5.6 | 6.0 | 5.6 | 5.2 | 5.1 | 5.5 | 2.8 | 2.4 | 2.7 | · | |
| Quick Ratio | 3.5 | 4.4 | 4.9 | 5.3 | 5.0 | 4.6 | 4.4 | 4.7 | 1.9 | 1.4 | 1.6 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -32.4 | -110.0 | -41.7 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | 0.7 | 0.8 | 1.1 | · | · | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 1.5 | · | |
| Receivables Turnover | 3.7 | 3.6 | 4.1 | 5.4 | 5.9 | 4.9 | 5.3 | 5.7 | · | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.97 | $8.06 | $7.90 | $6.89 | $5.42 | $4.25 | $3.57 | $3.00 | $1037.53 | $930.60 | $973.90 | · | |
| Revenue / Share | $4.83 | $6.39 | $6.52 | $5.76 | $4.66 | $3.41 | $3.20 | $2.74 | · | · | · | · | |
| Cash Flow / Share | $-0.69 | $0.32 | $0.30 | $0.72 | $0.89 | $0.44 | $0.55 | $0.28 | $0.07 | $0.03 | $-0.06 | · | |
| Cash / Share | $3.10 | $2.92 | $3.75 | $1.79 | $4.19 | $3.28 | $2.68 | $2.35 | $447.53 | $343.69 | $336.00 | · | |
| EPS (TTM) | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 | $0.12 | $0.30 | $0.11 | $-0.05 | $-0.30 | $-0.17 | $-0.22 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -23.7% | -2.6% | 34.6% | 3.9% | 41.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.00% | 10.8% | 25.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -46.2% | 42.9% | 366.7% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 53.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -46.2% | 44.2% | 365.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 53.4% | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $239M | $314M | $322M | $239M | $230M | $163M | $150M | $124M | $91M | $82M | · | · | |
| Net Income TTM | $-80M | $-20M | $21M | $40M | $28M | $6M | $14M | $5M | $-2M | $-12M | $-7M | $-8M | |
| Market Cap | $1.17B | $1.19B | $1.52B | $2.34B | $4.36B | $3.68B | $1.54B | $1.38B | $641.4K | $441.9K | $284.8K | · | |
| P/E | -14.6 | -59.0 | 72.6 | 60.7 | 163.0 | 660.2 | 114.6 | 284.2 | -310.0 | -36.2 | -42.0 | -41.0 | |
| P/S | 4.9 | 3.8 | 4.7 | 9.8 | 18.9 | 22.5 | 10.3 | 11.1 | 0.0 | 0.0 | · | · | |
| P/B | 3.4 | 3.0 | 3.9 | 7.0 | 16.8 | 18.7 | 9.6 | 10.4 | 0.0 | 0.0 | 0.0 | · | |
| P / Tangible Book | 3.4 | 3.0 | 4.0 | 7.0 | 16.8 | 18.9 | · | · | · | · | · | · | |
| P / Cash Flow | -34.1 | 75.9 | 104.4 | 65.5 | 99.1 | 175.6 | 59.7 | 108.2 | 0.2 | 0.4 | -0.1 | · | |
| P / FCF | -29.1 | -155.6 | -424.1 | 132.9 | 143.7 | 293.3 | 98.2 | 131.3 | 0.4 | -0.2 | -0.1 | · | |
| Earnings Yield | -6.9% | -1.7% | 1.4% | 1.7% | 0.61% | 0.15% | 0.87% | 0.35% | -0.32% | -2.8% | -2.4% | -2.4% |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $94M | $94M | $58M | $95M | $44M | $43M | $49M | $89M | $99M | $77M | $76M | $80M | $92M | $74M | $76M | |
| Cost of Revenue | $24M | $25M | $14M | $17M | $12M | $15M | $17M | $20M | $21M | $16M | $16M | $17M | $22M | $16M | $16M | |
| Gross Profit | $70M | $69M | $44M | $78M | $33M | $28M | $32M | $68M | $78M | $61M | $61M | $64M | $71M | $58M | $60M | |
| R&D Expense | $10M | $10M | $7M | $9M | $10M | $11M | $8M | $12M | $12M | $13M | $7M | $11M | $12M | $10M | $10M | |
| SG&A Expense | $60M | $61M | $67M | $59M | $63M | $85M | $60M | $63M | $67M | $63M | $50M | $57M | $62M | $55M | $47M | |
| Operating Income | $10M | $8M | $-23M | $18M | $-30M | $-57M | $-28M | $6M | $12M | $-2M | $10M | $6M | $9M | $3M | $14M | |
| Other Non-op | $394.0K | $443.0K | $2M | $353.0K | $120.0K | $131.0K | $283.0K | $139.0K | $63.0K | $330.0K | $304.0K | $71.0K | $10.0K | $63.0K | $27.0K | |
| Pretax Income | $11M | $8M | $-21M | $19M | $-26M | $-54M | $-30M | $13M | $10M | $-2M | $14M | $7M | $8M | $5M | $13M | |
| Income Tax | $3M | $3M | $-2M | $10M | $-9M | $-275.0K | $4M | $3M | $3M | $1M | $6M | $2M | $2M | $2M | $2M | |
| Net Income | $8M | $5M | $-18M | $9M | $-17M | $-54M | $-34M | $10M | $7M | $-3M | $8M | $5M | $6M | $3M | $10M | |
| EPS (Basic) | $0.16 | $0.10 | $-0.36 | $0.18 | $-0.34 | $-1.10 | $-0.69 | $0.20 | $0.15 | $-0.07 | $0.15 | $0.10 | $0.13 | $0.06 | $0.21 | |
| EPS (Diluted) | $0.16 | $0.10 | $-0.36 | $0.18 | $-0.34 | $-1.10 | $-0.69 | $0.20 | $0.15 | $-0.07 | $0.16 | $0.10 | $0.12 | $0.05 | $0.21 | |
| Shares (Basic) | 50,321,000 | 49,908,000 | · | 49,633,000 | 49,520,000 | 49,344,000 | · | 49,199,000 | 49,127,000 | 48,907,000 | · | 48,613,000 | 48,418,000 | 48,247,000 | 48,102,000 | |
| Shares (Diluted) | 51,501,000 | 50,900,000 | · | 50,549,000 | 49,520,000 | 49,344,000 | · | 49,731,000 | 49,811,000 | 48,907,000 | · | 49,370,000 | 49,516,000 | 49,500,000 | 49,549,000 | |
| EBITDA | $10M | $8M | · | $18M | $-30M | $-57M | · | $6M | $12M | $-2M | · | $6M | $9M | $3M | $14M |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $132M | $153M | $176M | $167M | $173M | $144M | $164M | $193M | $224M | · | $127M | $95M | $90M | $129M | |
| Short-term Investments | $33M | $32M | $34M | $17M | $23M | $50M | $86M | $72M | $42M | $21M | · | $61M | $97M | $114M | $82M | |
| Receivables | $98M | $81M | $50M | $60M | $34M | $40M | $78M | $105M | $94M | $65M | · | $112M | $94M | $63M | $55M | |
| Prepaid Expense | $5M | $7M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $8M | · | $6M | $5M | $5M | $4M | |
| Other Current Assets | $206.0K | $851.0K | $374.0K | $2M | $2M | $291.0K | $998.0K | $1M | $474.0K | $444.0K | · | $932.0K | $668.0K | $536.0K | $424.0K | |
| Current Assets | $342M | $312M | $312M | $321M | $293M | $326M | $368M | $397M | $384M | $366M | · | $347M | $328M | $313M | $297M | |
| PP&E (Net) | $70M | $72M | $73M | $73M | $74M | $75M | $85M | $82M | $78M | $72M | · | $63M | $56M | $53M | $48M | |
| PP&E (Gross) | $114M | $113M | $113M | $112M | $112M | $110M | $118M | $114M | $108M | $103M | · | $92M | $96M | $92M | $85M | |
| Accum. Depreciation | $44M | $42M | $40M | $39M | $37M | $35M | $34M | $32M | $31M | $30M | · | $29M | $40M | $39M | $37M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | $2M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | $165.0K | $171.0K | |
| Other Non-current Assets | $1M | $1M | $1M | $27M | $24M | $19M | $1M | $14M | $9M | $6M | · | $2M | $954.0K | $956.0K | $808.0K | |
| Total Assets | $475M | $451M | $452M | $456M | $438M | $457M | $510M | $538M | $513M | $493M | · | $472M | $441M | $419M | $395M | |
| Accounts Payable | $13M | $9M | $12M | $9M | $12M | $11M | $17M | $15M | $19M | $17M | · | $9M | $11M | $9M | $8M | |
| Current Liabilities | $73M | $61M | $69M | $62M | $59M | $68M | $70M | $66M | $66M | $63M | · | $57M | $54M | $47M | $45M | |
| Capital Leases | $30M | $31M | $32M | $34M | $35M | $33M | $35M | $35M | $31M | $31M | · | $32M | $28M | $28M | $26M | |
| Deferred Tax | · | · | · | $0 | $0 | $0 | $297.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | $2M | |
| Total Liabilities | $110M | $99M | $107M | $103M | $101M | $107M | $112M | $109M | $104M | $100M | · | $93M | $87M | $80M | $75M | |
| Common Stock | $505.0K | $502.0K | $498.0K | $497.0K | $495.0K | $495.0K | $493.0K | $493.0K | $492.0K | $491.0K | · | $488.0K | $485.0K | $483.0K | $482.0K | |
| Retained Earnings | $-135M | $-143M | $-148M | $-130M | $-139M | $-122M | $-68M | $-33M | $-43M | $-51M | · | $-55M | $-64M | $-70M | $-78M | |
| Treasury Stock | $6M | $6M | $6M | $6M | $4M | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $-7M | $-7M | $-7M | $-7M | $-6M | $-6M | $-7M | $-6M | $-5M | $-5M | · | $-3M | $-3M | $-937.0K | $-310.0K | |
| Stockholders' Equity | $365M | $352M | $344M | $354M | $337M | $350M | $397M | $428M | $409M | $393M | $386M | $379M | $354M | $339M | $320M | |
| Liabilities + Equity | $475M | $451M | $452M | $456M | $438M | $457M | $510M | $538M | $513M | $493M | · | $472M | $441M | $419M | $395M | |
| Shares Outstanding | 50,123,000 | 49,780,000 | 49,403,000 | 49,730,000 | 49,546,000 | 49,523,000 | 49,294,000 | 49,271,000 | 49,161,000 | 49,120,000 | · | 48,817,000 | 48,499,000 | 48,331,000 | 48,202,000 |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | · | $5M | $9M | $8M | $8M | $6M | $5M | $7M | $9M | $6M | $182.0K | $9M | $8M | $6M | $8M | |
| Deferred Tax | · | $3M | $-2M | $10M | $-10M | $-1M | $4M | $-13.0K | $-1.0K | $61.0K | $3M | $-10.0K | $18.0K | $57.0K | $-822.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $-156.0K | $-2.0K | $164.0K | $7.0K | $5.0K | |
| Operating Cash Flow | · | $-22M | $-4M | $3M | $-27M | $-6M | $642.0K | $4M | $-10M | $22M | $32M | $-6M | $-6M | $-5M | $20M | |
| CapEx | · | $443.0K | $2M | $883.0K | $2M | $1M | $6M | $6M | $6M | $5M | $3M | $9M | $3M | $3M | $8M | |
| Investing Cash Flow | · | $2M | $-19M | $5M | $25M | $35M | $-19M | $-35M | $-21M | $16M | $22M | $32M | $10M | $10M | $-104M | |
| Stock Repurchased | · | · | $0 | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | · | $-2M | $-50.0K | $983.0K | $-5M | $-948.0K | $-110.0K | $2M | $163.0K | $4M | $367.0K | $7M | $1M | $-1M | $-6M | |
| Net Change in Cash | · | $-21M | $-23M | $9M | $-6M | $29M | $-20M | $-29M | $-31M | $41M | $56M | $33M | $5M | $3M | $-91M | |
| Free Cash Flow | · | $-22M | · | · | · | $-7M | · | · | · | $16M | · | · | · | $-8M | · |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.6% | 73.6% | · | 82.2% | 74.0% | 65.8% | · | 77.3% | 79.2% | 78.9% | · | 79.2% | 76.6% | 78.3% | 79.5% | |
| Operating Margin | 10.8% | 8.5% | · | 19.5% | -67.6% | -134.8% | · | 6.4% | 12.0% | -2.9% | · | 7.8% | 9.3% | 3.8% | 18.0% | |
| Net Margin | 8.6% | 5.6% | · | 9.4% | -37.9% | -127.3% | · | 11.3% | 7.4% | -4.3% | · | 6.0% | 6.6% | 3.7% | 13.5% | |
| Pretax Margin | 11.8% | 8.8% | · | 19.8% | -58.5% | -127.9% | · | 14.8% | 10.4% | -2.9% | · | 8.4% | 9.2% | 6.4% | 16.5% | |
| EBITDA Margin | 10.8% | 8.5% | · | 19.5% | -67.6% | -134.8% | · | 6.4% | 12.0% | -2.9% | · | 7.8% | 9.3% | 3.8% | 18.0% | |
| ROA | · | · | · | 1.8% | -3.5% | -11.4% | · | 2.0% | 1.7% | -0.72% | · | 1.1% | · | 0.70% | 2.9% | |
| ROE | · | · | · | 2.3% | -4.5% | -14.6% | · | 2.5% | 2.1% | -0.89% | · | 1.4% | · | 0.88% | 3.6% | |
| ROIC | · | · | · | 2.5% | -5.8% | -16.3% | · | 1.0% | 2.1% | -0.88% | · | 1.2% | · | 0.47% | 3.5% |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 5.2 | 4.9 | 4.8 | · | 6.0 | 5.8 | 5.8 | · | 6.1 | · | 6.6 | 6.6 | |
| Quick Ratio | · | · | · | 4.1 | 3.8 | 3.8 | · | 5.1 | 5.0 | 4.9 | · | 5.3 | · | 5.7 | 5.9 |
Efficiency
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | · | 0.2 | 0.2 | |
| Receivables Turnover | · | · | · | 1.2 | 0.7 | 0.8 | · | 0.8 | 1.3 | 1.0 | · | 1.0 | · | 1.3 | 1.6 |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | $7.11 | $6.79 | $7.07 | · | $8.69 | $8.32 | $8.00 | · | $7.76 | · | $7.01 | $6.64 | |
| Revenue / Share | $1.82 | $1.84 | · | $1.87 | $0.90 | $0.86 | · | $1.78 | $1.99 | $1.58 | · | $1.63 | $1.86 | $1.49 | $1.53 | |
| Cash Flow / Share | · | $-0.43 | · | · | · | $-0.12 | · | · | · | $0.44 | · | · | · | $-0.10 | · | |
| Cash / Share | · | · | · | $3.54 | $3.37 | $3.50 | · | $3.33 | $3.92 | $4.56 | · | $2.61 | · | $1.86 | $2.68 | |
| EPS (TTM) | $0.08 | $-0.42 | · | $-1.95 | $-1.93 | $-1.44 | · | $0.44 | $0.34 | $0.31 | · | · | · | · | $0.95 |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $340M | $290M | · | $231M | $224M | $279M | · | $341M | $333M | $326M | · | $296M | $291M | $280M | $303M | |
| Net Income TTM | $4M | $-21M | · | $-96M | $-95M | $-71M | · | $22M | $17M | $15M | · | · | · | · | $47M | |
| Market Cap | · | · | · | $1.33B | $838M | $881M | · | $1.83B | $2.34B | $1.88B | · | $1.96B | · | $3.09B | $3.40B | |
| P/E | 347.4 | -48.1 | · | -13.7 | -8.8 | -12.4 | · | 84.6 | 140.0 | 123.5 | · | · | · | · | 74.3 | |
| P/S | · | · | · | 5.8 | 3.7 | 3.2 | · | 5.4 | 7.0 | 5.8 | · | 6.6 | 8.8 | 11.0 | 11.2 | |
| P/B | · | · | · | 3.8 | 2.5 | 2.5 | · | 4.3 | 5.7 | 4.8 | · | 5.2 | · | 9.1 | 10.6 | |
| P / Tangible Book | · | · | · | 3.8 | 2.5 | 2.5 | · | 4.3 | 5.7 | 4.8 | · | 5.2 | · | 9.2 | 10.7 | |
| P / Cash Flow | · | · | · | · | · | -153.6 | · | · | · | 86.7 | · | · | · | -606.7 | · | |
| Earnings Yield | 0.29% | -2.1% | · | -7.3% | -11.4% | -8.1% | · | 1.2% | 0.71% | 0.81% | · | · | · | · | 1.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-01-02 | 2024-12-27 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $239M | $314M | $322M | $239M | $230M |
| Gross Margin % | 76.2% | 76.3% | 78.4% | 78.5% | 77.5% |
| Operating Margin % | -38.3% | -4.0% | 8.7% | 15.4% | 14.5% |
| Net Income | $-80M | $-20M | $21M | $40M | $28M |
| Diluted EPS | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 |
| Metric | 2026-01-02 | 2024-12-27 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.5 | 5.2 | 5.6 | 6.0 | 5.6 |
| Quick Ratio | 3.5 | 4.4 | 4.9 | 5.3 | 5.0 |
| Metric | 2026-01-02 | 2024-12-27 | 2023-12-29 | 2022-12-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-40M | $-8M | $-4M | $18M | $30M |
Institutional owners (13F) 217 filers · $1.7B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
217
Value held
$1.7B
New positions
46
Exited positions
32
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 46 (-5 vs prior Q) | 32 (-15 vs prior Q) | 62 (+12 vs prior Q) | 58 (-11 vs prior Q) | +1.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BROADWOOD CAPITAL INC | $462,593,027 | 16,123,842 | 27.38% | Shares |
| BlackRock, Inc. | $193,116,808 | 6,731,154 | 11.43% | Shares |
| Madison Avenue Partners, LP | $119,802,210 | 4,175,748 | 7.09% | Shares |
| VANGUARD GROUP INC | $97,591,340 | 4,226,563 | 5.78% | Shares |
| Yunqi Capital Ltd | $93,447,060 | 3,257,130 | 5.53% | Shares |
| Point72 Asset Management, L.P. | $69,930,326 | 2,437,446 | 4.14% | Shares |
| GOLDMAN SACHS GROUP INC | $61,706,710 | 2,150,809 | 3.65% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $56,793,949 | 1,979,573 | 3.36% | Shares |
| STATE STREET CORP | $50,762,766 | 1,769,354 | 3.00% | Shares |
| Anatole Investment Management Ltd | $47,387,302 | 1,651,701 | 2.80% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $44,548,197 | 1,552,743 | 2.64% | Shares |
| MORGAN STANLEY | $37,759,504 | 1,316,119 | 2.23% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $30,878,411 | 1,076,006 | 1.83% | Shares |
| Two Seas Capital LP | $30,537,320 | 1,064,389 | 1.81% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $24,881,345 | 867,142 | 1.47% | Shares |
| AMERICAN CAPITAL MANAGEMENT INC | $24,290,647 | 846,659 | 1.44% | Shares |
| AI-Squared Management Ltd | $15,562,030 | 542,420 | 0.92% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $12,787,506 | 445,713 | 0.76% | Shares |
| NORTHERN TRUST CORP | $12,139,083 | 423,112 | 0.72% | Shares |
| NORGES BANK | $10,477,588 | 365,200 | 0.62% | Shares |
| UBS Group AG | $9,788,541 | 341,183 | 0.58% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $9,766,076 | 340,400 | 0.58% | Shares |
| Defender Capital, LLC. | $9,716,919 | 429,762 | 0.58% | Shares |
| Defilade Capital Management, L.P. | $9,241,795 | 322,126 | 0.55% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $9,238,295 | 322,004 | 0.55% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $6,942,292 | 241,976 | 0.41% | Shares |
| CITADEL ADVISORS LLC | $6,695,787 | 233,384 | 0.40% | Shares |
| Bank of New York Mellon Corp | $6,577,986 | 229,278 | 0.39% | Shares |
| Squarepoint Ops LLC | $5,402,097 | 188,292 | 0.32% | Shares |
| BANK OF AMERICA CORP /DE/ | $5,272,504 | 183,775 | 0.31% | Shares |
| Public Sector Pension Investment Board | $4,907,052 | 171,037 | 0.29% | Shares |
| Nuveen, LLC | $4,709,234 | 164,142 | 0.28% | Shares |
| CITADEL ADVISORS LLC | $4,226,037 | 147,300 | 0.25% | Call option |
| Invesco Ltd. | $3,827,734 | 133,417 | 0.23% | Shares |
| Freshford Capital Management, LLC | $3,586,250 | 125,000 | 0.21% | Shares |
| JPMORGAN CHASE & CO | $3,334,909 | 112,316 | 0.20% | Shares |
| TWO SIGMA INVESTMENTS, LP | $3,164,163 | 110,288 | 0.19% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,952,201 | 102,900 | 0.17% | Put option |
| RHUMBLINE ADVISERS | $2,935,101 | 102,305 | 0.17% | Shares |
| Legal & General Group Plc | $2,874,653 | 100,197 | 0.17% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,866,131 | 99,900 | 0.17% | Call option |
| JANUS HENDERSON GROUP PLC | $2,441,163 | 130,404 | 0.14% | Shares |
| ZACKS INVESTMENT MANAGEMENT | $2,377,671 | 82,874 | 0.14% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,341,133 | 81,601 | 0.14% | Shares |
| AMERIPRISE FINANCIAL INC | $2,234,664 | 77,890 | 0.13% | Shares |
| Linden Thomas Advisory Services, LLC | $1,938,956 | 67,583 | 0.11% | Shares |
| Meros Investment Management, LP | $1,864,850 | 65,000 | 0.11% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1,824,765 | 97,581 | 0.11% | Shares |
| UBS Group AG | $1,807,470 | 63,000 | 0.11% | Put option |
| Quantinno Capital Management LP | $1,743,204 | 60,760 | 0.10% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher, Richard T. LeBuhn ×41 filings | March 13, 2026 | 32.60% | Amendment | Passive investment | SEC |
| Yunqi Path Capital Master Fund, Yunqi Capital Limited, Yunqi Capital Cayman Limited, Christopher Min Fang Wang, Yunqi China Special Investment A, HS Group Master Fund II Ltd, HS Group (Hong Kong) Limited, HS Group Ltd ×8 filings | Jan. 16, 2026 | 6.50% | Amendment | · | SEC |
| July 22, 2015 | · | Initial filing | · | SEC | |
| Joern S. Joergensen, EuroEyes Holding AG | May 26, 2015 | · | Initial filing | Passive investment | SEC |
| Broadwood Partners, L.P. (1), Broadwood Capital, Inc., Neal C. Bradsher ×4 filings | Dec. 21, 2007 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 58 insiders · 32 officers · 28 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Warren Foust | President and CEO | Aug. 14, 2026 M | 95,816 | 0 | 0 | $0 |
| Stephen C Farrell | President & CEO | March 5, 2025 M | 35,156 | 0 | 0 | $0 |
| Thomas G Frinzi | President & CEO | Jan. 3, 2025 F | 70,519 | 0 | 0 | $0 |
| Caren L Mason | President & CEO | June 6, 2022 M | 152,415 | 0 | 0 | $0 |
| Deborah J Andrews | Chief Financial Officer & EVP | Aug. 14, 2026 M | 38,910 | 0 | 0 | $0 |
| Patrick F. Williams | Chief Financial Officer | March 12, 2025 M | 56,242 | 0 | 0 | $0 |
| Stephen P Brown | VP, Chief Financial Officer | March 21, 2017 A | 31,881 | 0 | 0 | $0 |
| John Bily | Chief Financial Officer | April 7, 2005 A | · | 0 | 0 | $0 |
| Donald J Todd | President, Asia/Pacific | June 7, 2012 S | 7,500 | 0 | 0 | $0 |
| Isamu Kamijo | President, STAAR Japan Inc. | Dec. 6, 2010 M | 23,334 | 0 | 0 | $0 |
| David Bailey | President, Int'l Operations | March 5, 2010 A | 1,140,000 | 0 | 0 | $0 |
| Gunther Roepstorff | President - Domilens GmbH | April 7, 2005 A | · | 0 | 0 | $0 |
| Magda Michna | Chief Development Officer | Aug. 14, 2026 M | 41,343 | 0 | 0 | $0 |
| Nathaniel Sisitsky | Chief Legal Officer | Dec. 11, 2025 F | 22,812 | 0 | 0 | $0 |
| Scott D Barnes | Chief Medical Officer | March 20, 2023 F | 41,502 | 0 | 0 | $0 |
| Keith Holliday | Chief Technology Officer | March 20, 2023 F | 28,157 | 0 | 0 | $0 |
| James E Francese | Sr. VP, Comm. Ops., NA, APAC | March 20, 2023 F | 42,660 | 0 | 0 | $0 |
| Samuel J Gesten | Chief Legal Officer | March 20, 2023 F | 43,665 | 0 | 0 | $0 |
| Robert Studholme | Senior VP, Operations | March 10, 2023 M | 31,980 | 0 | 0 | $0 |
| Hans-Martin Blickensdoerfer | Sr. VP, Comm. Ops, China | March 7, 2022 M | 83,110 | 0 | 0 | $0 |
| Graydon C. Hansen | Sr. VP, Global Operations | May 12, 2021 M | 9,801 | 0 | 0 | $0 |
| Jon K. Hayashida | VP, Global Clinical, Medical | May 10, 2021 M | 16,301 | 0 | 0 | $0 |
| Robin Hughes | Vice President, R&D | April 7, 2015 A | 41,075 | 0 | 0 | $0 |
| Philippe Subrin | Vice President, Switzerland Op | March 4, 2013 A | 56,500 | 0 | 0 | $0 |
| William Walter Goodmen | Global VP, Human Resources | Aug. 20, 2012 M | 15,000 | 0 | 0 | $0 |
| Craig Felberg | VP, R&D and Clinical Affairs | June 5, 2012 S | 8,700 | 0 | 0 | $0 |
| Donald L Fagen | V.P. Sales for N. America | March 2, 2012 S | 9,300 | 0 | 0 | $0 |
| Charles S Kaufman | V.P. , General Counsel | Aug. 26, 2011 S | 33,500 | 0 | 0 | $0 |
| Nicholas T Curtis | Sr. VP Sales and Marketing | May 15, 2008 A | 112,990 | 0 | 0 | $0 |
| Paul Hambrick | Vice President, Operations | Feb. 14, 2008 A | · | 0 | 0 | $0 |
| Robert Kenneth Lally | Vice President, QA/RA | April 2, 2007 A | · | 0 | 0 | $0 |
| James I Farnworth | VP Reg Affairs & Quality | April 7, 2005 A | · | 0 | 0 | $0 |
| Christopher Min Fang Wang | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Lilian Yansheng Zhou | Director | June 18, 2026 A | 8,101 | 0 | 0 | $0 |
| Wei Jiang | Director | June 18, 2026 A | 77,127 | 0 | 0 | $0 |
| Arthur C Butcher | Director | June 18, 2026 A | 9,549 | 0 | 0 | $0 |
| Richard T. LeBuhn | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Neal C. Bradsher | Director | June 18, 2026 A | · | 0 | 0 | $0 |
| Lou Silverman | Director | June 18, 2026 A | 11,158 | 0 | 0 | $0 |
| Elizabeth Yeu Lin | Director | June 18, 2025 A | 5,099 | 0 | 0 | $0 |
| Aimee S Weisner | Director | June 20, 2024 A | 15,352 | 0 | 0 | $0 |
| Gilbert H Kliman | Director | Dec. 1, 2023 A | 10,457 | 0 | 0 | $0 |
| Peony K Yu | Director | June 15, 2023 M | 2,786 | 0 | 0 | $0 |
| William P Wall | Director | Dec. 13, 2019 D | 16,489 | 0 | 0 | $0 |
| Richard A Meier | Director | May 20, 2016 S | 18,300 | 0 | 0 | $0 |
| Jack Steven Roush | Director | Aug. 6, 2015 P | 1,000 | 0 | 0 | $0 |
| Mark B Logan | Director | July 8, 2015 A | 46,696 | 0 | 0 | $0 |
| Charles P Slacik | Director | July 8, 2015 A | 18,798 | 0 | 0 | $0 |
| Barry G Caldwell | Director | June 9, 2014 A | 309,839 | 0 | 0 | $0 |
| Kathryn Tunstall | Director | June 9, 2014 A | 6,085 | 0 | 0 | $0 |
| Don M Bailey | Director | May 13, 2013 A | 108,937 | 0 | 0 | $0 |
| Donald Duffy | Director | May 14, 2012 A | 57,000 | 0 | 0 | $0 |
| David R Morrison | Director | Dec. 1, 2011 S | 40,000 | 0 | 0 | $0 |
| David L Schlotterbeck | Director | May 16, 2007 A | 10,000 | 0 | 0 | $0 |
| John R Gilbert | Director | May 28, 2004 A | · | 0 | 0 | $0 |
| Volker D Anhaeusser | Director | March 26, 2004 A | · | 0 | 0 | $0 |
| John C Moore | · | Dec. 2, 2020 D | 0 | 0 | 0 | $0 |
| Thomas R Paul | · | Feb. 10, 2006 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 48 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BRNY · EA Series Trust | 0.45% | 105,996 NS | July 31, 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.37% | 28,648 SH | Oct. 2, 2026 | Daily |
| SMDX · Tidal Trust III | 0.09% | 4,795 NS | July 31, 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.08% | 173,805 SH | Aug. 19, 2026 | Daily |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.08% | 30,816 SH | Aug. 19, 2026 | Daily |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.07% | 50,710 SH | Aug. 19, 2026 | Daily |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.07% | 7,186 SH | Oct. 2, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.05% | 28,285 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.05% | 32,542 SH | Aug. 19, 2026 | Daily |
| ESML · iShares Trust | 0.05% | 59,367 SH | Sept. 10, 2026 | Daily |
| IWO · iShares Trust | 0.05% | 284,925 SH | Sept. 11, 2026 | Daily |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 9,112 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 42,717 SH | Oct. 2, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 195,510 SH | Aug. 19, 2026 | Daily |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.03% | 8,113 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.03% | 16,201 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.03% | 867,418 SH | Sept. 11, 2026 | Daily |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.02% | 18,235 SH | Oct. 2, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 570,536 SH | Aug. 19, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.02% | 392,990 SH | Aug. 19, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.02% | 11,894 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.02% | 116,172 NS | July 31, 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.01% | 1,620 SH | Oct. 2, 2026 | Daily |
| ISCG · iShares Trust | 0.01% | 4,744 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.01% | 14,117 NS | July 31, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.01% | 683,432 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 3,156 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 89,405 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.01% | 2,757 SH | Sept. 10, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.00% | 4,605 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 79,553 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,995 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9,323 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 65,411 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 13,002 SH | Sept. 3, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 12,965 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 166 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 162 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 949,460 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,940 SH | Aug. 19, 2026 | Daily |
| IJR · iShares Trust | · | 3,034,270 SH | Sept. 10, 2026 | Daily |
| IJT · iShares Trust | · | 245,954 SH | Sept. 9, 2026 | Daily |
| IJS · iShares Trust | · | 214,230 SH | Sept. 8, 2026 | Daily |
| IWN · iShares Trust | · | 32,803 SH | Sept. 11, 2026 | Daily |
| XJR · iShares Trust | · | 6,834 SH | Aug. 31, 2026 | Daily |
| ISCB · iShares Trust | · | 1,321 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 3,628 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 7,283 SH | Sept. 1, 2026 | Daily |
STAA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 18 analysts
BUY
Median target
$27.00
+20.2%
3 16.7%
Strong Buy
5 27.8%
Buy
9 50.0%
Hold
1 5.6%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-10-03Mean target $27.70 +23.3%
Now
Current price $22.47
Low$19.00
Mean$27.70
High$37.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
| KIDS | $446M | -10.5 | 15.4% | -16.8% | -11.3% | 73.0% |
| CERS | $396M | -25.8 | 16.1% | -6.7% | -26.0% | · |
| SMTI | $209M | -5.4 | 19.0% | -36.4% | -165.7% | 92.7% |
| EMBC | $825M | 8.7 | -3.8% | 8.8% | -13.8% | 62.6% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026